Home NDC 0591-3713-00 Ezetimibe
Product NDC 0591-3713
Requested package NDC 0591-3713-00
11-digit product format 005913713
Labeler code 0591
Product ID 0591-3713_24aaf5ca-08e0-4db8-9734-cf2a606f8e57
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Ezetimibe
Dosage form TABLET
Route ORAL
Labeler Actavis Pharma, Inc.
Application ANDA200831
Marketing category ANDA
Marketing start 2017-06-12
Marketing end 2026-07-31
Substance EZETIMIBE
Active strength 10 mg/1
Pharmacologic classes Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]
NDC exclude flag No
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 21 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 21:27 UTC · source 2025-12-05 a6255e0c9aa5…a0211a219f2e…2025-08-26 23:59 UTC · source 2025-08-26 1d862106b807…00c93037cd84…2025-05-15 14:59 UTC · source 2025-05-14 390b4c401c3f…2c692c2daee3…2025-04-01 07:37 UTC · source 2025-03-31 e30019b0c005…a3f0b14938b7…2025-03-01 13:19 UTC · source 2025-02-28 bbbc9f937eca…946b9c97cf81…2025-02-27 05:24 UTC · source 2025-02-26 f268b84574a6…26285f5ac5df…2025-02-01 13:13 UTC · source 2025-01-31 f764e8902f78…92046438deef…2025-01-20 13:05 UTC · source 2025-01-17 68b1e3bced9e…98a755eb8bc6…2024-11-29 20:42 UTC · source 2024-11-29 05c55d027831…ca05dca9dc4c…2024-11-09 02:36 UTC · source 2024-11-08 48b4f40e6753…c7c7a00d2afa…2024-10-09 02:27 UTC · source 2024-10-08 27f29a85d7e4…1372111e901f…2024-07-10 04:00 UTC · source 2024-07-09 8d62ce987f31…9fe9ef23e30d…2024-05-28 21:11 UTC · source 2024-05-28 d1e113ab4d42…063ee3eb0a1d…2024-05-15 03:51 UTC · source 2024-05-14 50b4072663b7…eae3003ed65e…2022-04-09 23:13 UTC · source 2022-04-08 906f6e251498…bf70b80e44f0…2021-12-27 23:28 UTC · source 2021-12-27 6db9cb8d1e19…3449e1ec5b70…2021-02-18 23:40 UTC · source 2021-02-18 8fc7167e32ce…e96bbc724034…2020-12-18 03:04 UTC · source 2020-12-17 4184dd79f89f…545327b3e20f…2020-06-10 20:45 UTC · source 2020-06-10 4bd3596a7b87…5c64c6f6865f…2019-12-08 06:16 UTC · source 2019-12-05 263afe128892…91768de4ddbe…2019-06-01 22:24 UTC · source 2019-05-30 5b2001dcd8f5…54b53d4dc9e4…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A200831-001 EZETIMIBE EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A200831-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A200831-001 EZETIMIBE 10MG TABLET / ORAL AB 2017-06-12 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
Additional Listing Data#
Finished product No Active Ingredients# Ingredient, Strength table Ingredient Strength EZETIMIBE 10 mg/1
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0591-3713-05 Ezetimibe 500 in 1 BOTTLE TABLET 500 11 0591-3713-19 Ezetimibe 90 in 1 BOTTLE TABLET 90 11 0591-3713-30 Ezetimibe 30 in 1 BOTTLE TABLET 30 11
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0591-3713 EZETIMIBE TABLET [ACTAVIS PHARMA, INC.] 10 Current NDC, Legacy NDC, 3 package rows 20240601_f26e7a4e-b3d9-4cf8-baf0-7423d46cd8ba.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Status 0591-3713-00 00591371300 100000 TABLET in 1 BOX (0591-3713-00) 100000 tablet 12-JUN-17 28-FEB-27 Historical